Company: CERO
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001213900-25-010230
Chunk: 253

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 253
---
 Such option awards vest quarterly over a three-year period and expire ten years after the grant date. The vice chairman will receive $150,000 per annum, paid quarterly in advance. In addition, the vice chairman shall receive an option award to purchase 5,272 shares of common stock. Such option awards vest quarterly over a three-year period and expire ten years after the grant date. On September 30, 2024, the board of directors approved the grant of 2,550 options to each of our non-employee directors, which will vest (i) 50% upon the FDA’s acceptance of our IND and (ii) 50% upon the completion of a financing transaction generating at least $1.5 million of gross proceeds, in each case subject to such director’s continued service. Messrs. Atwood and Ehrlich and Dr. Corey each served as executive officers and directors during portions of 2024. Each of Mr. Atwood’s, Mr. Ehrlich’s and Dr. Corey’s compensation is summarized above in “ Executive Compensation—Employment Agreements.” Director Compensation Table The following table sets forth information regarding the compensation awarded to, earned by or paid to our non-employee directors for service on our board of directors during the year ended December 31, 2024.

| Name                |     | Fees Earned 
 or Paid in  
 Cash ($)    |        |    |     | Option         
 Awards (number 
 of shares)     |       |    |     | All Other    
 Compensation 
 ($)          |         |    |     | Total 
 ($)   |         |    |
|:--------------------|:----|:------------|-------:|---:|:----|:---------------|------:|---:|:----|:-------------|--------:|---:|:----|:------|--------:|---:|
| Michael Byrnes      |     | $           | 26,250 |    |     |                | 3,675 | -1 |     |              |       - |    |     | $     |  26,250 |    |
| Kathleen LaPorte    |     | $           | 26,250 |    |     |                | 3,675 | -1 |     |              |       - |    |     | $     |  26,250 |    |
| Lindsey Rolfe, M.D. |     | $           | 26,250 |    |     |